6 companies in Versant Ventures's investment portfolio.
Back to Versant Ventures profile“Creates biotechnology companies from in-house discovery labs using big pharma discipline and scientific rigor.”
Biopharmaceutical company focused on developing and commercializing novel therapeutics for dermatological conditions.
Biopharmaceutical company focused on developing therapies for fibrotic diseases, anemia, and cancer through innovative drug discovery.
Biotechnology company developing cancer immunotherapies targeting the CD47 pathway to enhance immune system recognition of cancer cells.
A company with limited publicly available information about its operations and focus area.
Portola Pharmaceuticals is an American clinical stage biotechnology company that researches, develops, and commercializes drugs.
Biotech company that developed cancer therapeutics targeting cancer stem cells before being acquired by AbbVie.
Versant Ventures has built a portfolio of 6 companies across 1 sector, including Biotech.
The portfolio reflects investments across the IPO, Series C stages, showing Versant Ventures's approach to supporting companies at multiple points in their growth journey.
Versant Ventures has invested in 6+ companies across 1 different sectors.
Versant Ventures's portfolio spans Biotech. This diversification reflects the firm's broad investment thesis and sector expertise.
Versant Ventures invests across the IPO, Series C stages. Their portfolio includes companies at various points in their growth journey.